|
ZN-c3 Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: Azenosertib, KP-2638, Study drug, azenosertib
Pipeline
Phase 1: 1Phase 2: 1
Top Sponsors
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2
Indications
- Cancer2
- Uterine Serous Carcinoma1
- Peritoneal Cancer1
- Fallopian Tube Cancer1
- Solid Tumor1
Anchorage, Alaska1 trial
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma
Alaska Women's Cancer Care
Phase 2
Aurora, Colorado1 trial
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.